Comparison of two aquaretic drugs (niravoline and OPC-31260) in cirrhotic rats with ascites and water retention

Journal of Pharmacology and Experimental Therapeutics

Volumn 289, Issue 1, 1999, Pages 194-201

  Bosch Marcé, Marta ^a   Poo, Jorge Luis ^a   Jiménez, Wladimiro ^a,b   Bordas, Nuria ^a   Leivas, Alberto ^a   Morales Ruiz, Manuel ^a   Muñoz, Rosa Maria ^a   Pérez, Manuel ^a   Arroyo, Vicente ^a   Rivera, Francisca ^a   Rodés, Juan ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; MESSENGER RNA; MOZAVAPTAN; NIRAVOLINE; VASOPRESSIN; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V2 RECEPTOR;

ANIMAL MODEL; ARTICLE; ASCITES; CONTROLLED STUDY; CREATININE CLEARANCE; DRUG EFFECT; EXPERIMENTAL MODEL; INTRAGASTRIC DRUG ADMINISTRATION; KIDNEY FUNCTION; LIVER CIRRHOSIS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SERUM OSMOLALITY; WATER RETENTION;

ALDOSTERONE; ANIMALS; BENZAZEPINES; BENZENEACETAMIDES; BODY WATER; BODY WEIGHT; CARBON TETRACHLORIDE POISONING; DIURETICS; HEMODYNAMIC PROCESSES; HORMONES; HYPOTHALAMUS; KIDNEY; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; OSMOLAR CONCENTRATION; PYRROLIDINES; RATS; RATS, WISTAR; RECEPTORS, OPIOID, KAPPA; RECEPTORS, VASOPRESSIN; RNA, MESSENGER; URODYNAMICS; VASOPRESSINS;

EID: 0032917959     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Arroyo V, Clària J, Saló J and Jiménez W (1994) Antidiuretic hormone and pathogenesis of water retention in cirrhosis with ascites. Semin Liver Dis 14:44-58.
2. Bellisant E, Denolle T, Sinnassamy P, Bichet DG, Giudicelli JF, Lecoz F, Gandon JM and Allain H (1996) Systemic and regional hemodynamic and biological effects of a new κ-opioid agonist, niravoline, in healthy volunteers. J Pharmacol Exp Ther 278:232-242.
3. Bosch-Marcé M, Jiménez W, Angeli P, Leivas A, Clària J, Graziotto A, Arroyo V, Rivera F and Rodés J (1995) Aquaretic effect of the κ-opioid agonist RU 51599 in cirrhotic rats with ascites and water retention. Gastroenterology 109:217-223.
4. Camps J, Solá J, Arroyo V, Pérez-Ayuso RM, Gaya J, Rivera F and Rodés J (1987) Temporal relationship between the impairment of free water excretion and antidiuretic hormone hypersecretion in rats with experimental cirrhosis. Gastroenterology 93:498-505.
5. Castro A, Jiménez W, Clària J, Ros J, Martínez JM, Bosch M, Arroyo V, Piulats J, Rivera F and Rodés J (1993) Impaired responsiveness to angiotensin II in experimental cirrhosis: Role of nitric oxide. Hepatology 18:367-372.
6. Foo N-C, Carter D, Murphy D and Ivell R (1991) Vasopressin and oxytocin gene expression in rat testis. Endocrinology 128:2118-2128.
7. Fort P, Marty L, Piechaczyk M, Sabrouty SE, Dani C, Janteur P and Blanchard JM (1985) Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigene family. Nucleic Acid Res 13:1431-1442.
8. Fujisawa G, Ishikawa S, Tsuboi Y, Okada K and Saito T (1993) Therapeutic efficacy of non-peptide ADH antagonist OPC-31260 in SIADH rats. Kidney Int 44:19-23
9. Ginés P, Berl T, Bernardi M, Bichet DG, Hamon G, Jiménez W, Liard JF, Martin PY and Schrier RW (1998) Hyponatremia in cirrhosis: From pathogenesis to treatment. Hepatology 28:851-864.
10. Guevara M, Ginés P, Férnandez-Esparrach G, Sort P, Salmerón JM, Jiménez W, Arroyo V and Rodés J (1998) Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion. Hepatology 27:35-41.
11. Hamon G and Jouquey S (1990) Kappa agonists and vasopressin secretion. Harm Res 34:129-132.
12. Jiménez W, Clària J and Arroyo V (1995) Experimental cirrhosis and pathogenesis of ascites formation in chronic liver disease, in Portal Hypertension (Holstege A, Schölmerich J and Hahn EG eds) pp 15-32, Kluwer Academic Publishers, London.
13. Jiménez W, Martinez-Pardo A, Arroyo V, Bruix V, Rimola A, Gaya J, Rivera F and Rodés J (1985) Temporal relationship between hyperaldosteronism, sodium retention and ascites formation in rats with experimental cirrhosis. Hepatology 5:245-250.
14. Kapusta DR and Obih JC (1993) Central kappa opioid receptor-evoked changes in renal function in conscious rats: Participation of renal nerves. J Pharmacol Exp Ther 267:197-204.
15. Kim JK, Summer SN, Howard RL and Schrier RW (1993) Vasopressin gene expression in rats with experimental cirrhosis. Hepatology 17:143-147.
16. Leander JD, Zerbe RL and Hart JC (1985) Diuresis and suppression of vasopressin by κ-opioids: Comparison with μ- and δ-opioids and clonidine. J Pharmacol Exp Ther 234:463-469.
17. Lenz K, Hörnatgl H, Druml W, Grimm G, Laggner A, Schneeweisz B and Kleinberger G (1989) Beneficial effect of 8-ornitine vasopressin on renal dysfunction in decompensated cirrhosis. Gut 30:90-96.
18. Moreau R, Cailmail S, Hamon G and Lebrec D (1996) Renal and haemodynamic responses to a novel kappa opioid receptor agonist, niravoline (RU 51599), in rats with cirrhosis. J Gastro Hepatol 11:857-863.
19. Nichols KM, Shapiro MD, Kluge R, Chung HM, Bichet DG and Schrier RW (1986) Sodium excretion in advanced cirrhosis: Effect of expansion of central blood volume and suppression of plasma aldosterone. Hepatology 2:235-238.
20. Ohnishi A, Orita Y, Okahara R, Fujihara H, Inoue T, Yamamura Y, Yabuuchi Y and Tanaka T (1993) Potent aquaretic agent: A novel nonpeptide selective vasopressin 2 antagonist (OPC-31260) in men. J Clin Invest 92:2653-2659.
21. Rossi NF and Brooks DP (1996) κ-opioid receptor agonist inhibition of osmotically induced AVP release: Preferential action at hypothalamic sites. Am J Physiol 270:E367-E372.
22. Sawyer WH, Pang PKT, Seto J, McEnroe M, Lammek B and Manning M (1981) Vasopressin analogues that antagonize antidiuretic responses by rats to the antidiuretic hormone. Science (Wash DC) 212:49-51.
23. Slizgi GR and Ludens JH (1982) Studies on the nature and mechanism of the diuretic activity of the opioid analgesic ethylketocyclazocine. J Pharmacol Exp Ther 220: 585-591.
24. Stassen FL, Bryan W, Gross M, Kavanagh B, Shue D, Sulat L, Wiebelhaus VD, Yim N and Kinter LB (1983) Critical differences between species in the in vivo and in vitro renal responses to antidiuretic hormone antagonists. Prog Brain Res 60:395-403.
25. Tsuboi Y, Ishikawa SE, Fujisawa G, Okada K and Saito T (1994) Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats. Kidney Int 46: 237-244.
26. Yamada K, Imai M and Yoshida S (1989) Mechanism of diuretic action of U-62066E, a κ-opioid agonist. Eur J Pharmacol 160:229-237.
27. 2 receptor antagonist. Br J Pharmacol 105: 787-791.